Companies /Healthcare

Bio-Rad Laboratories Inc - Class A

NYSE: BIO Medical Devices
$389.94
â–² $1.30 (+0.33%) today
Markets closed · 1:59am ET
Today · % change

24/7 Wall St. View

Fundamentals

Market Cap
$10.4B
P/E Ratio
47.6
Profit Margin
8.6%
Revenue (TTM)
$2.6B
EPS (TTM)
$8.20
52-Week Range
$237 – $396
Street Target
$329.00

About Bio-Rad

Bio-Rad Laboratories Inc, headquartered in Hercules, California, is a global leader in developing and providing innovative tools for the life science research and clinical diagnostic markets. Founded in 1952, the company specializes in products and systems for separating, purifying, characterizing, and quantitating biological materials such as cells, proteins, and nucleic acids. Bio-Rad serves a wide range of customers, including those in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Additionally, it supplies test systems, informatics systems, and quality controls for healthcare facilities. Bio-Rad markets its products worldwide, leveraging both a direct sales force and a network of distributors.

BIO Coverage